Product
Naloxone + Lofexidine
1 clinical trial
3 indications
Indication
Opioid WithdrawalIndication
Opioid Use DisorderIndication
Opioid CravingClinical trial
Assessing a Clinically-meaningful Opioid Withdrawal PhenotypeStatus: Recruiting, Estimated PCD: 2025-11-30